癌细胞通过SLC3A2介导的氨酸吸收限制了T细胞在肝细胞癌中的活性
Yating Chang1, Naizhen Wang1, Shaopeng Li2
1Xiamen University, Xiamen, China.
Cancer research
|March 24, 2025
概括
肝细胞癌 (HCC) 细胞通过耗尽素来破坏T细胞免疫力. 补充氨酸可能会提高用伦瓦提尼布和抗PD-1免疫疗法治疗HCC的疗效.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 代谢途径 代谢途径
背景情况:
- 异常的氨基酸代谢对于肝细胞癌 (HCC) 的进展,免疫逃避和入侵至关重要.
- 以前的研究集中在瘤细胞内的代谢重编程上,忽视了瘤与免疫细胞的相互作用.
研究的目的:
- 调查氨基酸代谢失调在HCC和T细胞之间的交叉作用中的作用.
- 探索调节氨酸代谢在HCC治疗中的治疗潜力.
主要方法:
- 对T细胞中HCC细胞对氨酸吸收干扰的分析.
- 评估STAT3水平,T细胞增殖和在lysine剥夺下效应器功能.
- 研究素载体SLC3A2在HCC细胞中的表达及其与临床结果的相关性.
- 评估c-Myc-SLC3A2轴在伦瓦提尼布治疗耐药性的评估.
- 在HCC模型中测试氨酸补充剂与伦瓦替尼和抗PD-1免疫疗法的疗效.
主要成果:
- HCC细胞通过竞争性抑制T细胞的氨酸吸收来降低T细胞免疫力.
- 在T细胞中素缺乏会降低STAT3水平,阻碍增殖和效应器功能,从而促进瘤的进展.
- 在HCC中SLC3A2的高表达与患者的生存率差以及T细胞基因表达的改变相关.
- 一个c-Myc-SLC3A2调节轴有助于伦瓦替尼抗性.
- 氨酸补充剂增强了瘤对伦瓦替尼和抗PD-1联合治疗的敏感性.
结论:
- HCC和T细胞之间的失调的素代谢是促进瘤进展的关键机制.
- 向氨酸代谢,特别是通过补充剂,为HCC提供了一个有前途的治疗策略.
- 氨酸补充剂可以克服对氨酸激酶抑制剂的耐药性,并提高HCC中免疫检查点阻塞的有效性.
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
Abnormal Proliferation
4.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.3K
Adaptive Mechanisms in Cancer Cells
5.5K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.5K
Lysosomal Hydrolases
3.7K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.7K


